TCL Archive Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors. February 23, 2007
TCL Archive Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy July 26, 2013
TCL Archive In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements February 19, 1988
